Xinjiang Bai Hua Cun Pharma Tech (600721.SH) disclosed its third quarter report for 2024, achieving operating income of 2....
According to the Zhitong Finance app, Xinjiang Bai Hua Cun Pharma Tech (600721.SH) disclosed its third quarter report for 2024, with operating income of 0.291 billion yuan, a year-on-year increase of 9.38%; net income attributable to the parent company was 23.95 million yuan, a year-on-year increase of 35.39%; non-net profit was 21.7 million yuan, a year-on-year increase of 32.52%; and basic earnings per share were 0.0627 yuan.